A Decade of Re-operative Adult Cardiac Surgery with Del Nido Cardioplegia.

Document Type

Article

Publication Date

2-17-2026

Publication Title

The Journal of Thoracic and Cardiovascular Surgery

Abstract

OBJECTIVE: Evaluate safety and efficacy of del Nido (DN) and blood cardioplegia (BC) in adult re-operations over a 10-year period.

METHODS: Between April 2014 and March 2024, 696 adult patients underwent cardiac re-operations at our center with DN (N=325) or BC (N=369). Propensity-score matching by preoperative characteristics yielded 287 pairs. The primary outcome was myocardial protection, assessed by postoperative troponin T levels (cTnT) and left ventricular ejection fraction (LVEF). Secondary outcomes included 30-day complications and long-term survival.

RESULTS: Matched cohorts were balanced in demographics, risk factors, operative status, and surgical indication. DN was associated with shorter aortic cross-clamp (AXC) (121±60 vs 189±87 minutes, P< .0001) and cardiopulmonary bypass times (177±90 vs 256±111 minutes, P< .0001), and lower intra-operative glucose levels (176±43 vs 195±51 mg/dL, P< .0001). Thirty-day mortality, stroke, renal failure, atrial fibrillation, or mechanical circulatory support were similar between cohorts. Subgroup stratification by AXC time found lower cTnT with DN when AXC < 120 minutes (0.3[0.2,0.6] vs 0.4[0.3,0.7] ng/mL, P=.0257), but no difference at 121-180 or ≥180 minutes. Follow-up echocardiography was available in 91.1% at 2.8±2.7 years and revealed comparable LVEF (DN:52.3±13.2%, BC:52.5±13.1%; P=.8247). Nine-year survival was equivalent (63.2% vs 65.3%; P=.7913).

CONCLUSION: Del Nido cardioplegia offered comparable myocardial protection and perioperative outcomes overall, and equivalent long-term survival compared to blood cardioplegia in adult cardiac re-operations. However, AXC-stratified analysis revealed clinically relevant subgroup differences that warrant further investigation.

DOI

10.1016/j.jtcvs.2026.02.006

ISSN

1097-685X

PubMed ID

41713701

Share

COinS